AIM

AIM ImmunoTech
AIM

14 hedge funds and large institutions have $4.63M invested in AIM ImmunoTech in 2014 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$123K
2
+$92.3K
3
+$30.8K
4
PSC
Piper Sandler & Co
Minnesota
+$15.4K
5
Renaissance Technologies
Renaissance Technologies
New York
+$15.4K

Top Sellers

1
-$30.8K
2
-$15.4K
3
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.62M
2
$1.59M
3
$732K
4
$288K
5
$87K
6
$76K
7
$54K
8
$28K
9
$26K
10
$24K
11
$22K
12
$21K
13
$12K
14
$10K
15
$9K
16
$8K
17
$6K
18
$5K
19
$3K
20
$3K
21
$3K
22
$2K
23
$1K
24
–